Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,847 Skin Cancer
clinical trials

Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC-Coraopolis/Heritage Valley Radiation Oncology
2108
mi
from 91732
Moon, PA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Essentia Health - Park Rapids
1487
mi
from 91732
Park Rapids, MN
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Newland Medical Associates-Pontiac
1957
mi
from 91732
Pontiac, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Charles Health System-Redmond
725
mi
from 91732
Redmond, OR
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Delbert Day Cancer Institute at PCRMC
1485
mi
from 91732
Rolla, MO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Siteman Cancer Center at Saint Peters Hospital
1553
mi
from 91732
Saint Peters, MO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Summit Cancer Care-Candler
2130
mi
from 91732
Savannah, GA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
South Jordan Health Center
558
mi
from 91732
South Jordan, UT
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Baptist Memorial Hospital and Cancer Center-Desoto
1590
mi
from 91732
Southhaven, MS
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Rockwood North Cancer Treatment Center
945
mi
from 91732
Spokane, WA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Bhadresh Nayak MD PC-Sterling Heights
1971
mi
from 91732
Sterling Heights, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Promedica Flower Hospital
1930
mi
from 91732
Sylvania, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Ascension Saint Joseph Hospital
1960
mi
from 91732
Tawas City, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Thief River Falls Medical Center
1483
mi
from 91732
Thief River Falls, MN
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Gene Upshaw Memorial Tahoe Forest Cancer Center
382
mi
from 91732
Truckee, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Macomb Professional Building
1968
mi
from 91732
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Memoral Sloan Kettering Westchester
2447
mi
from 91732
Harrison, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
UPMC CancerCenters, Hilman Cancer Center
2122
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
John Wayne Cancer Institute at Providence Saint John's Health Center
26
mi
from 91732
Santa Monica, CA
Click here to add this to my saved trials
Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial Clinical Trial
Registry Study for Talimogene Laherparepvec
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
1600
mi
from 91732
Germantown, TN
Click here to add this to my saved trials
Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial Clinical Trial
Registry Study for Talimogene Laherparepvec
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
2127
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial Clinical Trial
Registry Study for Talimogene Laherparepvec
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
827
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial Clinical Trial
Registry Study for Talimogene Laherparepvec
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Royal Brisbane and Women's Hospital
7198
mi
from 91732
Brisbane,
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.
Status: Enrolling, Phase I, II
Updated: 12/31/1969
John Wayne Cancer Institute at Providence Saint John's Health Center
26
mi
from 91732
Santa Monica, CA
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Care Cancer Center - Bolivar
1395
mi
from 91732
Bolivar, MO
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Caldwell
666
mi
from 91732
Caldwell, ID
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Fairview Maple Grove Medical Center
1503
mi
from 91732
Maple Grove, MN
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
Status: Enrolling, Phase II
Updated: 12/31/1969
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
1358
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Pali Momi Medical Center
2575
mi
from 91732
'Aiea, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
The Cancer Center of Hawaii-Pali Momi
2572
mi
from 91732
'Aiea, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Aurora Cancer Care-Southern Lakes VLCC
1706
mi
from 91732
Burlington, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Essentia Health Saint Mary's - Detroit Lakes Clinic
1452
mi
from 91732
Detroit Lakes, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Walter Knox Memorial Hospital
682
mi
from 91732
Emmett, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Hawaii Cancer Care Inc-Liliha
2571
mi
from 91732
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
OptumCare Cancer Care at Fort Apache
217
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Marshfield Medical Center-Marshfield
1646
mi
from 91732
Marshfield, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
The West Clinic - Mid-Town
1589
mi
from 91732
Memphis, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Lakeland Hospital Niles
1799
mi
from 91732
Niles, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Reid Health
1860
mi
from 91732
Richmond, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Epic Care Cyberknife Center
349
mi
from 91732
Walnut Creek, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Fairview Lakes Medical Center
1531
mi
from 91732
Wyoming, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Study in Subjects With Small Primary Choroidal Melanoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
W. K. Kellogg Eye Center, University of Michigan
1931
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Princess Margaret Cancer Center - University Health Network
2158
mi
from 91732
Toronto,
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of a CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 (Pembrolizumab) and of NKTR-214 in Combination With Anti-PD-L1 (Atezolizumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
New Brunswick
2410
mi
from 91732
New Brunswick, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Study CB-839 in Combination With Nivolumab in Patients With Melanoma, ccRCC and NSCLC
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Karmanos Caner Center
1966
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
Advanced BRAFV600 Wild-type Melanoma Clinical Trial
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Michigan; Michigan Institute for Clinical and Health Research (MICHR)
1931
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Advanced BRAFV600 Wild-type Melanoma Clinical Trial
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Cancer Center- Aurora
824
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Advanced BRAFV600 Wild-type Melanoma Clinical Trial
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Onc-Central Austin CA Ct
1209
mi
from 91732
Austin, TX
Click here to add this to my saved trials
Advanced BRAFV600 Wild-type Melanoma Clinical Trial
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
TriHealth Hatton Institute; Surgical Education
1879
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Advanced BRAFV600 Wild-type Melanoma Clinical Trial
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Parkview Physicians Group
1854
mi
from 91732
Fort Wayne, IN
Click here to add this to my saved trials
Advanced BRAFV600 Wild-type Melanoma Clinical Trial
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic Cancer Center- Hillcrest
2045
mi
from 91732
Mayfield Heights, OH
Click here to add this to my saved trials
Advanced BRAFV600 Wild-type Melanoma Clinical Trial
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Minnesota Oncology Minneapolis
1509
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Advanced BRAFV600 Wild-type Melanoma Clinical Trial
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Thomas Jefferson University Hospital;Medical Oncology
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Advanced BRAFV600 Wild-type Melanoma Clinical Trial
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Florida Cancer Specialists PAN
1977
mi
from 91732
Tallahassee, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection
Status: Enrolling, Phase
Updated: 12/31/1969
509
1287
mi
from 91732
Graz,
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
1462
mi
from 91732
Jefferson City, MO
Click here to add this to my saved trials
Melanoma Clinical Trial
A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
6113
mi
from 91732
Caba,
Click here to add this to my saved trials
Melanoma Clinical Trial
A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Stanford Cancer Center SC-2
328
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
QUILT-3.055: A Study of ALT-803 in Combination With PD-1/PD-L1 Checkpoint Inhibitor in Patients With Advanced Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Research Joplin
1333
mi
from 91732
Joplin, MO
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
QUILT-3.055: A Study of ALT-803 in Combination With PD-1/PD-L1 Checkpoint Inhibitor in Patients With Advanced Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Clinical Research
1314
mi
from 91732
Sioux Falls, SD
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Dana Farber Can Ins
2575
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Columbia University Medical Center; Clinical Research Management Office
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Skin Cancer Clinical Trial
Using Technology to Scale-Up an Occupational Sun Protection Policy Program
Status: Enrolling
Updated: 12/31/1969
Kaiser Foundation Research Institute
350
mi
from 91732
Oakland, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - Aurora
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - Boston
2576
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - Indianapolis
1791
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - Seattle
962
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
Status: Enrolling, Phase
Updated: 12/31/1969
Local Institution
7233
mi
from 91732
Lismore,
Click here to add this to my saved trials
Oncology Clinical Trial
MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Princess Margaret Cancer Centre
2159
mi
from 91732
Toronto,
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Memoral Sloan Kettering Westchester
2447
mi
from 91732
Harrison, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Prostaglandin Inhibition and PD-1/CTLA4 Blockade in Melanoma
Status: Enrolling, Phase II
Updated: 2/27/2018
University of Califonia, San Francisco
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Carcinoma, Basal Cell Clinical Trial
PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Colorado Hospital, Anschutz Outpatient Pavilion
825
mi
from 91732
Denver, CO
Click here to add this to my saved trials
Melanoma Clinical Trial
Yervoy Pregnancy Surveillance Study
Status: Enrolling
Updated: 2/15/2018
UBC
2124
mi
from 91732
Morgantown, WV
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of NKTR-262 in Combination With NKTR-214 and With NKTR-214 Plus Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumor Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - Scottsdale
353
mi
from 91732
Scottsdale, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of NKTR-262 in Combination With NKTR-214 and With NKTR-214 Plus Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumor Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - Tampa
2135
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
[Site 13] Frederick Memorial Hospital d/b/a James M Stockman Cancer Institute
2258
mi
from 91732
Frederick, MD
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California, San Diego (UCSD) Moores Cancer Center
94
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
HuMax-AXL-ADC Safety Study in Patients With Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Roswell Park Comprehensive Cancer Center
2181
mi
from 91732
Buffalo, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and/or Trametinib Rollover Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
Mary Crowley Research Center
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
Pace Dermatology Associates
935
mi
from 91732
Lakewood, WA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
Midwest Allergy Sinus Asthma, SC ( Site 0081)
1650
mi
from 91732
Normal, IL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
Owensboro Dermatology Associates
1739
mi
from 91732
Owensboro, KY
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
Mosaic Dermatology
27
mi
from 91732
Santa Monica, CA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatology Associates of Seattle
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
7513
mi
from 91732
North Sydney,
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Our Lady of the Lake Physicians Group - Medical Oncology
1588
mi
from 91732
Baton Rouge, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Canton
1944
mi
from 91732
Canton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Caro Cancer Center
1957
mi
from 91732
Caro, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Care Specialists of Illinois - Decatur
1645
mi
from 91732
Decatur, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Ohio Breast and Endocrine Surgery
1967
mi
from 91732
Gahanna, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Care Cancer Center - Garden City
993
mi
from 91732
Garden City, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Aurora Health Care Germantown Health Center
1721
mi
from 91732
Germantown, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Care Cancer Center - Great Bend
1110
mi
from 91732
Great Bend, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
OptumCare Cancer Care at Seven Hills
218
mi
from 91732
Henderson, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
University Cancer Center
216
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
OptumCare Cancer Care at MountainView
217
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Sechler Family Cancer Center
2307
mi
from 91732
Lebanon, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Hope Cancer Clinic
1949
mi
from 91732
Livonia, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph London
1906
mi
from 91732
London, KY
Click here to add this to my saved trials
1 … 55 56 57 58 59 60 61 62 63 64 65 66 67 68